Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Ornbjerg, Lykke; Brahe, Cecilie; Askling, Johan; Ciurea, Adrian; Mann, Herman; ÖNEN, FATOŞ; Kristianslund, Eirik; Nordstrom, Dan; Santos, Maria; Codreanu, Catalin; Gomez-Reino, Juan; Rotar, Ziga; Gudbjornsson, Bjorn; Di Giuseppe, Daniela; Nissen, Michael; Pavelka, Karel; Birlik, AHMET; Kvien, Tore; Eklund, Kari; Barcelos, Anabela; Ionescu, Ruxandra; Sanchez-Piedra, Carlos; Tomsic, Matija; Geirsson, Arni; Loft, Anne; van der Horst-Bruinsma, Irene; Jones, Gareth; Iannone, Florenzo; Hyldstrup, Lise; Krogh, Niels; Hetland, Merete; Ostergaard, Mikkel

doi:10.1136/annrheumdis-2019-215427

Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Ornbjerg L. M., Brahe C. H., Askling J., Ciurea A., Mann H., ÖNEN F., ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.78, sa.11, ss.1536-1544, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 78 Sayı: 11
Basım Tarihi: 2019
Doi Numarası: 10.1136/annrheumdis-2019-215427
Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1536-1544
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective To study drug retention and response rates in patients with axial spondyloarthritis (axSpA) initiating a first tumour necrosis factor inhibitor (TNFi).